Since its inception in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Today, with hundreds of major innovations to their credit, the Rigaku Group of Companies are world leaders in the fields of general X-ray diffraction (XRD), thin film analysis (XRF, XRD and XRR), X-ray fluorescence spectrometry (TXRF, EDXRF and WDXRF), small angle X-ray scattering (SAXS), protein and small molecule X-ray crystallography, Raman spectroscopy, X-ray optics, semiconductor metrology (TXRF, XRF, XRD and XRR), X-ray sources, computed tomography, nondestructive testing and thermal analysis.
With Rigaku's vast understanding of X-ray and its complementary technologies as a foundation, our true strength is seen in an unparalleled willingness to collaborate with customers. By promoting partnerships, dialog, and innovation within the global scientific and industrial communities, Rigaku demonstrates a relentless commitment to providing our client markets with fully integrated solutions.
The company and its employees are dedicated to developing and supplying universities, industry, and government labs with the ultimate in customer-focused integrated solutions across a wide variety of disciplines, including structural proteomics, nanoengineering research, general purpose X-ray diffraction (XRD) and spectroscopy (XRF), materials analysis and quality assurance.
About Rigaku Americas Holding Company, Inc.
Wholly owned by Rigaku Corporation, RAH was established as a Delaware corporation in 2014 to consolidate Rigaku operations in North America. Major subsidiaries include: Rigaku Americas Corporation (The Woodlands, Texas), Applied Rigaku Technologies (Austin, Texas), Rigaku Innovative Technologies (Auburn Hills, Michigan), Rigaku Reagents (Seattle, Washington) and Rigaku Analytical Devices (Wilmington, Massachusetts).